Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (528)	8/26/1999 5:22:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 579

ammended filing, with some useful stuff in it...... ITEM 10. ADDITIONAL INFORMATION. The information set forth in Item 10(f) of the Schedule 14D-1 is hereby amended and supplemented as follows: Section 253(a) of the Delaware Law has recently been amended to provide that in order to effect a "short-form" merger a corporation must own 90% of the stock of only those classes of outstanding shares that would be entitled to vote on a merger (previously it was necessary to own 90% of the stock of all classes of outstanding shares whether or not such classes were entitled to vote on a merger). Therefore, if Offeror purchases 90% or more of the outstanding shares of Common Stock in the Offer it will have the ability to cause a "short-form" merger to be consummated whether or not Offeror has acquired the outstanding share of the Series B Convertible Preferrred Stock.